Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
about
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentNovel therapeutics for Alzheimer's disease: an updateMelatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases'The clocks that time us'--circadian rhythms in neurodegenerative disordersMelatonin in Alzheimer's disease and other neurodegenerative disordersMercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cellsSevere Cognitive Dysfunction and Occupational Extremely Low Frequency Magnetic Field Exposure among Elderly Mexican AmericansVirtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6).Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by CitrateComplementary and alternative medicines for Alzheimer's disease.Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide.Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.The circadian clock and pathology of the ageing brain.Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer diseaseHyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.Disassembly of preformed amyloid beta fibrils by small organofluorine moleculesPhysiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.Frontiers in Alzheimer's disease therapeutics.Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.Melatonin Therapy in Patients with Alzheimer's Disease.Role of melatonin in Alzheimer-like neurodegeneration.Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.Therapeutic approaches for prion and Alzheimer's diseases.Small molecule inhibitors of Abeta assembly.Natural products as a source of Alzheimer's drug leads.Melatonin in Alzheimer's diseaseMelatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?The development of new therapeutics for Alzheimer's disease.Computational insights into the development of novel therapeutic strategies for Alzheimer's disease.Melatonin as a natural ally against oxidative stress: a physicochemical examination.A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.Roles of AMP-activated protein kinase in Alzheimer's disease.Intranasal therapeutic strategies for management of Alzheimer's disease.Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.
P2860
Q22241837-92460172-AA83-4102-8004-A2AB29C7A6D8Q24620383-2AA5E11E-3DE1-4A10-A5CB-F318A773BB21Q26772733-055376F8-7371-44A6-AB56-375DD331B4BAQ26824646-9CF91682-A65A-4A2F-B0E4-4EA353D61847Q28217483-5947B17A-38B5-438C-A142-8F2C92A81AF4Q28378252-BB343889-83C9-4CA0-9303-8A6A28768054Q28385828-47337BD1-DDBC-406F-962F-1A496361CB42Q28546473-F4F4742D-3C0A-495D-B1C8-8705B0912A8EQ30805913-F0F09698-880A-4C40-9C28-E03A6D5FDBDEQ30855109-EF85102C-51C6-4C96-9576-AFEF49546068Q31052453-6751C6F9-3DF0-4CAC-83B5-23F046529974Q33392254-1368CEC9-28F1-45B2-9364-AC16AE1D8CB2Q33514614-EF7E52E2-2727-4629-95A8-8C60D303597BQ33609573-A201381D-1DCF-4EA4-AD65-152594289406Q33834203-63B57562-555C-4F35-BA76-123BA4E1F8EEQ33965466-31000BC0-DC27-4914-BBC8-8101C06BD100Q34155629-116E82A4-BE1F-487B-9305-BBC4CEB85CFEQ34259247-EF906F69-5589-4D85-A6D8-9C02BADF5239Q34402167-55EBE370-EBD0-4193-85A8-9EE4689A2B2FQ34553059-CFF9D952-7A47-4D19-96EB-7DB3FEFF3751Q34669333-376500EA-509F-457B-83B6-76C263FF4FB6Q34721350-ADA5A71A-5F0E-4BC9-BA94-9F6D0860F42DQ35086876-7B175D47-C699-4C72-BA7F-F50E8555D3C4Q35801168-DC8C3893-F03F-430B-982C-A84FBFDAB4DBQ36335048-9963243D-3F73-4EEA-ABDA-D66506F5E34FQ36346522-E77676D9-3809-496A-BB7D-F50B6C512EF1Q36433222-06D47C4E-F473-42A8-8585-9D2C3F270702Q36872884-A3C06817-A93E-490D-85AE-27B0D861DEECQ36911406-CAFD96D7-3620-448B-8625-91EA3A2AFAFAQ37029561-D396A5F5-68CF-49D1-A197-72F6D90EA745Q37091982-FCDC49D2-3062-4AF3-A2D2-D311AF90F6E0Q37612356-DB88E822-2CAF-48E6-8E28-201155275E88Q37784685-BBEDDAB2-BEF8-46A0-81AA-0FCA0E6ED8DDQ37855869-E71829CC-4B29-4767-BE5D-2892743CAE82Q37900675-45E8A0CE-20DD-4707-9CF6-76C3641F93E0Q37981246-A29C20A7-09C5-49CC-B46E-F6A7006AFC24Q37988399-A473F7AD-2A48-4C2F-83F2-8E43AE2768F8Q38176935-FA295AAE-1634-4B91-8632-C21D39D98705Q38558352-E74C576D-07C3-42F8-95FA-CB5FA5053EBEQ38834700-D4090B84-68A4-472B-A34D-D39B66C4215D
P2860
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@ast
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@en
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@nl
type
label
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@ast
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@en
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@nl
prefLabel
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@ast
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@en
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@nl
P2093
P356
P1476
Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
@en
P2093
Frangione B
Pappolla M
Robakis NK
Zagorski M
P304
P356
10.1074/JBC.273.13.7185
P407
P577
1998-03-01T00:00:00Z